Carbon‐Based Nanomaterials for Antiviral Applications
Source abstract
Abstract
Abstract In the antimicrobial resistance era, carbon‐based nanomaterials (CBNs) such as fullerenes, carbon dots, graphene, and their derivatives are promising therapeutic tools in combating viral diseases. This review shows that these materials have broad‐spectrum antiviral activity against 33 viruses belonging to different Baltimore groups. CBNs also exhibit antimicrobial activity against bacteria and fungi and possess a low risk of selecting for resistance, since their primary mode of antimicrobial action involves physically damaging the microbes. CBNs also offer additional promising properties, including enhanced antiviral effectiveness under diverse types of irradiation and facilitating antiviral immune responses. Their potential as antiviral agents is still in its infancy and future research should focus on their toxicity, antiviral mechanisms, pharmacokinetics, and bioavailability. They are also potential antiviral materials for preventing the transmission of viral diseases for use in face masks, shields, hospital and airport surfaces, and elevators, among others. It is anticipated that CBNs will play an increasingly significant role in the fight against viruses and infectious diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Carbon and Quantum Dots Applications · Graphene research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biomaterials and Bioengineering Lab Centro de Investigación Traslacional San Alberto Magno Universidad Católica de Valencia San Vicente Mártir Valencia 46001 Spain
Center for iPS Cell Research and Application (CiRA) Kyoto University Kyoto 606‐8397 Japan
University of Southern Denmark Mads Clausen Institute NanoSYD, Alsion 2 Sønderborg 6400 Denmark
Machine Biology Group Departments of Psychiatry and Microbiology Institute for Biomedical Informatics Institute for Translational Medicine and Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia PA 19104 USA
Departments of Bioengineering and Chemical and Biomolecular Engineering School of Engineering and Applied Science University of Pennsylvania Philadelphia PA 19104 USA
Department of Chemistry School of Arts and Sciences University of Pennsylvania Philadelphia PA 19104 USA
Penn Institute for Computational Science University of Pennsylvania Philadelphia PA 19104 USA
Funding
Ministerio de Ciencia e Innovación
References (100+)
Show source-provided references
1. WHO WHO Director‐General's Opening Remarks at the Media Briefing on COVID‐19 11 March 2020 2020.
2. 10.1016/j.cartre.2020.10001910.1016/j.cartre.2020.100019 ↗
3. 10.1021/acsnano.1c0062910.1021/acsnano.1c00629 ↗
4. 10.1016/j.ijbiomac.2022.08.03910.1016/j.ijbiomac.2022.08.039 ↗
5. Gupta R. K. · 2023
6. Birkett M. · 2022 · 1162
7. Tuñón‐Molina A. · ACS Appl. Mater. Interfaces · 2021
8. 10.1039/c1cc11877c10.1039/c1cc11877c ↗
9. 10.3390/app1105231110.3390/app11052311 ↗
10. 10.1128/br.35.3.235-241.197110.1128/br.35.3.235-241.1971 ↗
11. Nader K. · 2023 · 1
12. Saleem J. · 2018 · 1800525
13. 10.1002/adfm.20210119510.1002/adfm.202101195 ↗
14. 10.1021/acs.bioconjchem.7b0003010.1021/acs.bioconjchem.7b00030 ↗
15. 10.1002/smll.20190620610.1002/smll.201906206 ↗
16. 10.1021/acsami.5b0687610.1021/acsami.5b06876 ↗
17. 10.1016/j.carbon.2016.09.03210.1016/j.carbon.2016.09.032 ↗
18. 10.1002/mabi.20160049910.1002/mabi.201600499 ↗
19. 10.1016/j.mencom.2012.09.00910.1016/j.mencom.2012.09.009 ↗
20. 10.1021/acsami.6b0168110.1021/acsami.6b01681 ↗
21. 10.1016/j.colsurfb.2014.09.02510.1016/j.colsurfb.2014.09.025 ↗
22. 10.1021/am405040z10.1021/am405040z ↗
23. 10.1039/C9NR05273A10.1039/C9NR05273A ↗
24. 10.1002/adhm.20160081210.1002/adhm.201600812 ↗
25. 10.1016/j.jcis.2019.02.01010.1016/j.jcis.2019.02.010 ↗
26. 10.1016/j.msec.2019.11005210.1016/j.msec.2019.110052 ↗
27. 10.1016/j.antiviral.2015.03.00610.1016/j.antiviral.2015.03.006 ↗
28. 10.3390/ijerph1304043010.3390/ijerph13040430 ↗
29. 10.1021/es300340u10.1021/es300340u ↗
30. 10.1021/ez500126910.1021/ez5001269 ↗
31. 10.1021/es101496710.1021/es1014967 ↗
32. 10.1016/j.carbon.2012.02.03810.1016/j.carbon.2012.02.038 ↗
33. 10.1038/s41598-016-0028-x10.1038/s41598-016-0028-x ↗
34. 10.1021/acsabm.8b0015410.1021/acsabm.8b00154 ↗
35. Chatterjee S. · 2023 · 103601
36. 10.1039/c1cc12209f10.1039/c1cc12209f ↗
37. 10.1016/j.bmcl.2003.09.01610.1016/j.bmcl.2003.09.016 ↗
38. 10.1080/1536383970801331010.1080/15363839708013310 ↗
39. 10.1021/jacs.9b0800310.1021/jacs.9b08003 ↗
40. 10.1016/j.bmcl.2016.08.08610.1016/j.bmcl.2016.08.086 ↗
41. 10.1016/j.ijbiomac.2020.12.15110.1016/j.ijbiomac.2020.12.151 ↗
42. 10.1002/smll.20200709110.1002/smll.202007091 ↗
43. 10.1021/acsomega.2c0798110.1021/acsomega.2c07981 ↗
44. 10.1039/C7NR06520E10.1039/C7NR06520E ↗
45. 10.1021/bm301665810.1021/bm3016658 ↗
46. 10.1038/nchem.238710.1038/nchem.2387 ↗
47. 10.1039/C7TB01379E10.1039/C7TB01379E ↗
48. 10.1002/adfm.20160647710.1002/adfm.201606477 ↗
49. 10.1016/j.pdpdt.2006.08.00310.1016/j.pdpdt.2006.08.003 ↗
50. 10.1016/j.pdpdt.2014.02.00910.1016/j.pdpdt.2014.02.009 ↗
51. Ivanova V. T. · 2012 · 012019
52. Song Z. · Small · 2015 · 11 · 1771
53. 10.1021/acsami.2c2131910.1021/acsami.2c21319 ↗
54. 10.1016/B978-0-12-819786-8.00022-010.1016/B978-0-12-819786-8.00022-0 ↗
55. Castro E. · 2017 · 6523
56. 10.1080/1536383X.2019.170649510.1080/1536383X.2019.1706495 ↗
57. Ruiz‐Hitzky E. · 2020 · 2000979
58. 10.1080/22221751.2018.156345910.1080/22221751.2018.1563459 ↗
59. 10.1016/j.vaccine.2015.03.09410.1016/j.vaccine.2015.03.094 ↗
60. 10.1016/j.vaccine.2014.04.03510.1016/j.vaccine.2014.04.035 ↗
61. 10.1016/j.vetmic.2014.09.00310.1016/j.vetmic.2014.09.003 ↗
62. 10.1128/MMBR.69.3.462-500.200510.1128/MMBR.69.3.462-500.2005 ↗
63. 10.1007/s00705-018-3874-y10.1007/s00705-018-3874-y ↗
64. 10.1128/JCM.02820-1310.1128/JCM.02820-13 ↗
65. 10.1016/j.colsurfb.2021.11217210.1016/j.colsurfb.2021.112172 ↗
66. 10.1186/1477-3155-8-110.1186/1477-3155-8-1 ↗
67. 10.3201/eid1807.12019010.3201/eid1807.120190 ↗
68. 10.1016/S1369-7021(11)70161-410.1016/S1369-7021(11)70161-4 ↗
69. Mohajeri M. · 2018 · 298
70. 10.3390/ijms2115521110.3390/ijms21155211 ↗
71. 10.1002/smll.20220615410.1002/smll.202206154 ↗
72. Lee C. · 2015 · 193
73. 10.1021/acsami.9b1503210.1021/acsami.9b15032 ↗
74. 10.1039/C6RA21062G10.1039/C6RA21062G ↗
75. 10.1021/acs.bioconjchem.8b0044810.1021/acs.bioconjchem.8b00448 ↗
76. 10.1016/j.carbon.2014.11.00710.1016/j.carbon.2014.11.007 ↗
77. 10.1007/s11814-014-0049-810.1007/s11814-014-0049-8 ↗
78. 10.3390/microorganisms1103068110.3390/microorganisms11030681 ↗
79. 10.1007/s11094-014-1053-310.1007/s11094-014-1053-3 ↗
80. 10.1021/acsanm.0c0271310.1021/acsanm.0c02713 ↗
81. Mochalin V. N. · 2012 · 11
82. 10.1038/s41598-016-0001-810.1038/s41598-016-0001-8 ↗
83. Lim S. Y. · 2015 · 362
84. 10.1016/j.colsurfb.2013.05.02210.1016/j.colsurfb.2013.05.022 ↗
85. 10.3390/ijms1911336510.3390/ijms19113365 ↗
86. 10.1021/acs.est.7b0192210.1021/acs.est.7b01922 ↗
87. 10.1002/jbm.a.3594610.1002/jbm.a.35946 ↗
88. 10.1016/j.biomaterials.2015.11.02810.1016/j.biomaterials.2015.11.028 ↗
89. Orecchioni M. · 2016 · 163
90. 10.1002/adhm.20150060610.1002/adhm.201500606 ↗
91. 10.1021/acsnano.5b0475110.1021/acsnano.5b04751 ↗
92. 10.1039/c3nr03543c10.1039/c3nr03543c ↗
93. 10.1016/j.biomaterials.2011.09.09110.1016/j.biomaterials.2011.09.091 ↗
94. 10.1016/j.biomaterials.2012.06.06410.1016/j.biomaterials.2012.06.064 ↗
95. Mukherjee S. P. · 2017
96. 10.1002/smll.20110239310.1002/smll.201102393 ↗
97. 10.1016/j.carbon.2015.11.07610.1016/j.carbon.2015.11.076 ↗
98. 10.1039/C2TB00025C10.1039/C2TB00025C ↗
99. Williams D. F. · Front Bioeng Biotechnol. · 2019 · 7
100. 10.1021/cr500537t10.1021/cr500537t ↗